Nadex Advertisement
Interactive Brokers Advertisement
Home > Boards > US OTC > Biotechs >

Abattis Bioceuticals Corp. (ATTBF)

Add ATTBF Price Alert      Hide Sticky   Hide Intro
Moderator: Goodbuddy4863, guay, captainscotty, ebota12, GreenBrickRoad
Search This Board: 
Last Post: 7/20/2017 2:10:24 PM - Followers: 315 - Board type: Free - Posts Today: 0

Welcome to Abattis Bioceuticals Corp.

Abattis Bioceuticals Corp. (the "Company" or "Abattis") (OTCQB: ATTBF) (CSE: ATT), is a specialty biotechnology company with capabilities through its wholly-owned subsidiaries as a botanical drug development company that develops and licenses natural health products, medicines, extractions and ingredients for the biologics, nutraceutical, bioceutical and cosmetic markets, some of which will contain cannabinoid compounds. Abattis develops and is in the process of commercializing natural health products that target ailments and satisfy important market needs. Abattis is conducting ongoing research and development to create plant-based intellectual property and ingredients. Current areas of focus are growth through acquisition and business development and cash flow through commercialization of existing assets.

Through our divisions Biocell Labs Inc. and Vergence Sales & Marketing Group, we develop and license natural health products and have future plans to expand into the nutraceutical, pharmaceutical and cosmetic markets. The Company has an extensive pipeline of high-quality products and intellectual property for the rapidly expanding natural health product market. We follow strict standard operating protocols, and adhere to the applicable laws of Canada and foreign jurisdictions.

Within our other divisions Northern Vine, North American Bioextracts and Biocube we have capabilities that support the production and extraction of botanical ingredients for our products; one of which includes cannabis.

Northern Vine LaboratoriesTM (Northern Vine Labs
TM) seeks to become the premier analytical testing laboratory, and research and development partner to the legal cannabis industry in Canada - Executive Overview

For more information, visit the Company's website at:

Our investors are forward thinkers in the emerging bioceutical and medical marijuana markets. We are a specialty, vertically-integrated biotechnology company that aggregates, incubates, integrates and invests in the natural health product and botanical drug development industry. From patented and proprietary formulations, extraction and processing methods, Abattis consistently seeks opportunities to participate in varied markets all connected by a common global purpose and customer base: seeking health through natural products. Abattis is uniquely positioned to fully exploit the growing trend toward marijuana legalization in the United States and medicinal use in Canada as licensed and international jurisdictions.


“Health Canada estimates that the emerging medical marijuana market to be in excess of $1 billion.
Stephen Easton, an SFU Economist, estimated that nationally the Cannabis industry generates approximately $19 to $21 billion”

We develop and license natural health products with unique botanical blends, CBD and proprietary ingredients. These infused food and beverage brands are designed for wellness nutraceuticals, medical foods & botanical drugs market with future plans to expand into the pharmaceutical and cosmetic markets.


Canada’s cannabis industry is expected to surpass $22 billion in size over the coming years, according to Deloitte, with over 140,000 registered medical marijuana patients today. With about 40 licensed producers under the ACMPR, the industry is expected to see a shortfall in supply given the 205% compound annual growth rate in registered patients since June of 2014 along with the near-term plans to legalize marijuana for recreational use.

As an investor, you are our partner and we take this relationship seriously. Please contact us if you have any questions or if you would like to invest in Abattis.

Goldman Small Cap Research report, 'This Stock Set to Double Thanks to New License'
Abattis Bioceuticals Corp. - Stock Up Big on Recent News, Greater Gains on Horizon (October 20, 2016).

Goldman Small Cap Research report 
'The Next Industry-Changing Specialty Health Stock'
Abattis Bioceuticals Corp. - Major Revenue Ahead for Innovative, Diversified Bioceuticals Pioneer (June 13, 2016).

Northern Vine Labs™ is getting ready for our launch.

Visit our website and join our community for updates and educational information.
#knowyourbud #abattis #northernvinelabs 


Northern Vine Labs™ are now on Health Canada list for licensed dealers!
The table below contains a list of laboratories that have a current Dealers Licence under the Narcotic Control Regulations and who are licensed to conduct activities with cannabis:

Northern Vine Labs™, a subsidiary of Abattis, seeks to become the premier analytical testing laboratory, and research and development partner to the legal cannabis industry in Canada. The ability to legally work with Cannabis remains rare and highly specialized. Northern Vine Labs™ Controlled Substance License enables proprietary methods and services to be offered to currentlicensed producers within Canada’s existing Federal regulatory structure. It also offers Northern Vine Labs™ customers, including Abattis, the ability to formulate and develop new products containing cannabinoid ingredients in advance of the end to prohibition.

In partnership with the BC Institute of Technology (BCIT), Northern Vine Labs™ has been working to develop new and improved methods for the analysis of cannabis. This work is expected to be published by BCIT positioning NV Labs as the industry expert in analytical services which are substantially faster and more reliable than any other in Canada. Utilizing these proprietary methods, Northern Vine Labs will offer for sale its analytical reference standards enabling market participants to check quality and metrological traceability of products, to validate analytical measurement methods, and/or to support the proper calibration of instruments.

Northern Vine Labs™ operations under the CSL will include:
1. Analytical Services
2. Research and Development Services
3. Extraction to Support Analysis and R&D?
In future, NV Labs anticipates the opportunity to amend its license to include:
4. Extraction service for sale of extracted ingredients
5. Importation/Exportation

Analytical Services
Potency Testing Determining composition and concentration of various cannabinoid compounds
Moisture Analysis and Foreign Matter Testing
Microbiological Testing
Ensuring the safety of products by testing for levels of mold and bacteria.

The Cannabis Trade Alliance of Canada, which represents producers, said the new regime should provide for mandatory testing: 

“Mandatory laboratory testing of all cannabis products (potency and contaminants) – a critical step in the seed-to-sale process when considering public health, and should be the main objective in the legalized framework.”

Report of the Task Force on Cannabis Legalization and Regulation


Vergence Visionary Bioceuticals, a subsidiary of Abattis, is a team of nutraceutical marketing and brand specialists focused on innovative health products to penetrate the fast growing market for natural, safe and effective solutions to two of society’s unresolved and ubiquitous health issues: Pain caused by inflammation and mental ailments common to our modern lifestyle. Vergence is the exclusive exporter of 99.6%, organic and pure CBD Isolate out of Hong Kong and directly to the rest of the world. Together with a vast distribution network and custom product and branded formulations via Northern Vine Labs, Vergence aims to promote healthy living through natural remedies. Vergence is in possession of over 100 Natural Product Numbers (NPN's) as granted by Health Canada and plans to develop and distribute these products into global markets for end use.

Abattis Bioceuticals Corporation
Address: 104 - 9295 198th Street | Langley, BC V1M 3J9 | Canada
Phone: 778-883-7869 (Corporate Communications: Brook Bellian)

Abattis Bioceuticals
Phone: (604) 336.0881

Northern Vine
(604) 336.0881 | (604) 371.3371 | (604) 888.1129

CHINA | Dr. Shuang Xie  Ph. D.
Suzhou Raybot Material Tech Ltd
T: 17785884380 | C: 17783175968
Phone: 86 5125240581 | 8613901388668
Address:  No. 10-1 Yang Yuan Road,
Xinzhuang Zhen,Changshu | China

There are an unlimited number of common shares without par value authorized for issue. At September 30, 2016, there were 111,760,004 issued and fully paid common shares and 1,750,000 common shares in treasury.

Issued & Outstanding (07/01/2017)The Company has 159,656,060 common shares issued and outstanding (source

System for Electronic Document Analysis and Retrieval (SEDAR) -


07/17/2017 | Abattis Obtains DTC Eligibility
07/15/2017 | Abattis Partners with the CSE & Stockpools
06/15/2017 | New Key Executive and Management Positions
06/13/2017 | Abattis Provides Company Update
06/07/2017 | Abattis Announces New Board Members
05/10/2017 | Northern Vine Labs Expands Its Sales Team
05/03/2017 | Official Launch of Northern Vine Laboratory
04/26/2017 | Abattis Signed Exclusive Destribution Agreement
04/10/2017 | Abattis Bioceuticals Announces New CEO
04/06/2017 | Abattis Gets Added to the Marijuana Index by MJIC
04/04/2017 | Near-term Legalization Puts Testing into Focus
03/27/2017 | Next Month - Legislation to Legalize Marijuana in CA
03/20/2017 | Dr. David Galvez - New Science Advisor of Northern Vine
03/13/2017 | Abattis Team Positions for Next Stage of Growth
03/07/2017 | LP Highlights Continued Need for Testing
02/25/2017 | Abattis Prepares to Launch Northern Vine Labs
02/24/2017 | Abattis Annual Report - September 30, 2016
02/14/2017 | Abattis Audit Update
02/08/2017 | Key Shortcomings in Canada's Cannabis Industry
02/03/2017 | Abattis Audit Update
12/16/2016 | Abattis Provides Corporate Update
12/09/2016 | $ 5 Million Facility with Aluminia Partners
11/15/2016 | Dr. Shuang Xie - Director and CTA
11/09/2016 | Licensing Deal and Brand Acouisition
11/07/2016 | Renewal of Health Canada Licence
11/02/2016 | Appointment of New Independent Director
10/24/2016 | Agreement to Acquire 100% of Experion
10/17/2016 | Experion Prepares for Construction
10/05/2016 | MOU with Global Damon Pharma of South Korea
10/03/2016 | Northern Vine Receives Controlled Substance Licence

If you want to add or to change something on this site - send a message to guay.
Current Price
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
#29239  Sticky Note ABATTIS BIOCEUTICALS: Joins an Index and Runs with captainscotty 04/16/17 08:15:16 AM
#28505  Sticky Note ATTBF Now Listed on the Marijuana Index-Biotechnology sector: Goodbuddy4863 04/02/17 07:18:06 PM
#27284  Sticky Note Goldman Research thinks ATTBF could blow through $0.30+ GreenBrickRoad 10/21/16 11:19:22 AM
#26399  Sticky Note Corporate Update ebota12 11/05/15 07:31:44 PM
#12064  Sticky Note BOARD WARNING - Please Read: IH Admin [Shelly] 06/09/14 01:18:32 PM
#30020   I guess I was wrong about that... Att_for_life 07/20/17 02:10:23 PM
#30019   The Rotary Evaporator at work at Northern Vine Labs guay 07/20/17 01:54:27 PM
#30018   Ready to go!! Starting the cup, let's get make it happen 07/19/17 11:13:43 AM
#30017   ATTBF Abattis Bioceuticals Corp.Abattis Bioceuticals Corp. OTCQB Logo Silver Tree 1999 07/19/17 10:59:25 AM
#30016   Yeah...maybe $0.01 and $0.005 if they issue another ebota12 07/19/17 10:45:06 AM
#30015   Potential acquisitions? hmm. Looks like we shouldn't be oatsuzn 07/18/17 04:05:02 PM
#30014   Abattis is also in the late stages of guay 07/18/17 03:47:20 PM
#30013   .125 $ATTBF jjr04001 07/18/17 01:24:13 PM
#30012   ATTBF recent chart is showing an uptick in StormanNorman 07/18/17 08:41:52 AM
#30011   I agree. Everything in this sector is connected oatsuzn 07/17/17 08:10:14 PM
#30010   Ironically, the pump is on:) Att_for_life 07/17/17 07:54:15 PM
#30009   If it didn't follow the ETF up, why dangerx 07/17/17 12:00:08 PM
#30008   Abattis Obtains DTC Eligibility guay 07/17/17 10:42:51 AM
#30007   Yup, repeating bottom to .02 Att_for_life 07/15/17 08:00:53 AM
#30006   My opinion doesn't matter... Att_for_life 07/15/17 07:58:21 AM
#30005   A good report - thank you for posting! guay 07/14/17 04:45:04 PM
#30004 make it happen 07/14/17 02:18:46 PM
#30003   I guess it's better than nothing.. but that's GreenBrickRoad 07/13/17 07:32:19 PM
#30002   It's not awesome, it's quite stupid really. I ebota12 07/13/17 06:49:53 PM
#30001   This is awesome shark! Thanks for the info. make it happen 07/13/17 06:44:27 PM
#30000   Today's email: shark300feet 07/13/17 12:21:20 PM
#29999   MA 50 and MA 100 moving down. Silver Tree 1999 07/11/17 09:02:27 PM
#29998   It broke but I think it moves higher. Mfbosox 07/11/17 08:09:41 PM
#29997   .10 support broken. New low under way. Silver Tree 1999 07/11/17 07:25:32 PM
#29996   Ok - I went and looked. Appears that StarFishPatrick 07/10/17 07:20:14 PM
#29995   Watch insider filings - have to be made StarFishPatrick 07/10/17 07:15:07 PM
#29993   In summer 2018 Silver Tree 1999 07/09/17 08:51:18 AM
#29992   New to ATTBF but find this a very Xpedian 07/08/17 04:25:15 PM
#29991   PSAR FLIPPED $ATTBF jjr04001 07/07/17 04:43:29 PM
#29990   Added today $ATTBF jjr04001 07/07/17 03:07:32 PM
#29989   Agreed. Adding shares at these levels will jjr04001 07/02/17 11:35:42 AM
#29988   It is Hot Hot Hot Silver Tree 1999 06/28/17 03:29:57 PM
#29987   when it hits 7's and 8's? akaoni 06/28/17 10:50:12 AM
#29986   The MACD is about to go viral make it happen 06/28/17 10:27:37 AM
#29985   #ATTBF: Great time to add in the single captainscotty 06/27/17 07:15:00 PM
#29984   It's a RIPE TIME for doubt to settle... Will dangerx 06/27/17 09:32:04 AM
#29983   What is MACD. What says crossover is near? Skittles9 06/26/17 01:52:02 PM
#29982   MACD crossover. Turning point is near. jjr04001 06/26/17 11:54:53 AM
#29981   #ATTBF: Ready for some 0.10's...:-] captainscotty 06/24/17 09:25:10 AM
#29980   I know that just because the index is Skittles9 06/23/17 10:44:08 AM
#29979   fine by me, let them sell to pay Lvannoy88 06/23/17 09:20:25 AM
#29978   They dancing around 12 but insider itching sell more Silver Tree 1999 06/23/17 07:32:18 AM
#29977   'dangelx' As a matter of fact, YES! 4/6 Shaark 06/22/17 12:38:18 PM
#29976   Could be that ATT will be pushed even guay 06/22/17 11:54:26 AM
#29975   #ATTBF: Got my bid in ATT: life...:-) 0.06 captainscotty 06/21/17 11:51:37 PM
#29974   Starting to wonder if Rene finally earned the ebota12 06/21/17 08:48:59 PM
#29973   The bottom is at.01. It will get there Skittles9 06/21/17 05:47:56 PM
#29972   ATTBF... .1260...Chart...looking for break/hold of 200ma and a georgie18 06/21/17 08:49:47 AM
#29971   Att_for_life how do You rate this matter? guay 06/20/17 10:27:06 AM
#29970   When snow will be reflected in eye retina, guay 06/20/17 10:06:10 AM